Global Eubiotics Market
By Type (Prebiotics, Probiotics, organic acids), By Form (Liquid form, Dry form), By Function (Yield, Immunity, Productivity), By Region (North America, South America, Europe, Asia Pacific, Rest of World), By Livestock (Poultry, Ruminants, Aquatic animals)
Market Overview:
The Global Eubiotics Market was valued at USD 4.80 billion in 2016 and is projected to reach USD 9.13 billion by 2025, growing at a CAGR of 7.40% from 2017 to 2025.
Eubiotics improve the immune system of the body. They are natural digestive stimulants that create healthy balance of microflora. These are good for digestive health and are a substitute to antibiotics. Eubiotics have gained attention in human as well as animal feed additives. This market has gained more importance due to the ban on antibiotics in many countries.
Sample Infographics:
Market Dynamics:
1. Market Drivers
1.1 High demand for animal protein.
1.2 High demand for manufactured animal feed.
1.3 More awareness about the feed quality.
2. Market Restraints
2.1 Rise in price of raw materials.
2.2 Major lack of awareness in most countries.
Market Segmentation:
The Global Eubiotics Market is segmented on the basis of Type, Form, Function, Livestock and Region.
1. By Type:
1.1 Prebiotics
1.1.1 Fructo-Oligosaccharides (FOS)
1.1.2 Mannan-Oligosaccharide (MOS)
1.1.3 Galacto-Oligosaccharides (GOS)
1.2 Probiotics
1.2.1 Lactobacilli
1.2.1.1 Research on Lactobacilli
1.2.2 Bifidobacteria
1.2.2.1 Research on Bifidobacteria
1.2.3 Streptococcus Thermophilus
1.2.4 Other Bacteria
1.3 Organic Acids
1.3.1 Lactic Acid
1.3.2 Propionic Acid
1.3.3 Formic Acid
1.3.4 Acetic Acid
1.3.5 Fumaric Acid
1.4 Essential Oils
2. By Form:
2.1 Liquid form
2.2 Dry form
3. By Function:
3.1 Yield
3.2 Nutrition & Gut Health
3.3 Immunity
3.4 Productivity
4. By Region:
4.1 North America (U.S., Canada, Mexico)
4.2 Europe (Germany, UK, France, Rest of Europe)
4.3 Asia Pacific (China, India, Japan, Rest of Asia Pacific)
4.4 Rest of World.
5. By Livestock:
5.1 Poultry
5.1.1 Key features
5.1.1.1 Growth and Improved Feed Conversion Rate
5.2 Ruminants
5.3 Aquatic Animals
5.4 Other Livestock
5.5 Swine
5.5.1 Key Features
5.5.1.1 Protection Against Infection
5.5.1.2 Stimulate and Neutralize
Competitive Landscape:
The major players in the market are as follows:
1. BASF SE
2. Koninklijke DSM N.V.
3. Novozymes
4. Lesaffre Group
5. Lallemand, Inc.
6. Behn Meyer Group
7. Advanced Bio Nutrition Corp
8. Cargill
9. E.I. Dupont De Nemours and Company
10. Chr. Hansen Holding A/S
These major players have adopted various organic as well as inorganic growth strategies such as mergers & acquisitions, new product launches, expansions, agreements, joint ventures, partnerships, and others to strengthen their position in this market.
RESEARCH METHODOLOGY OF VERIFIED MARKET INTELLIGENCE:
Research study on the Global Eubiotics Market was performed in five phases which include Secondary research, Primary research, subject matter expert advice, quality check and final review.
The market data was analyzed and forecasted using market statistical and coherent models. Also market shares and key trends were taken into consideration while making the report. Apart from this, other data models include Vendor Positioning Grid, Market Time Line Analysis, Market Overview and Guide, Company Positioning Grid, Company Market Share Analysis, Standards of Measurement, Top to Bottom Analysis and Vendor Share Analysis.
To know more about the Research Methodology of Verified Market Intelligence and other aspects of the research study, kindly get in touch with our sales team.
1 INTRODUCTION OF GLOBAL EUBIOTICS MARKET
1.1 Overview of the Market
1.2 Scope of Report
1.3 Assumptions
2 EXECUTIVE SUMMARY
3 RESEARCH METHODOLOGY OF VERIFIED MARKET INTELLIGENCE
3.1 Data Mining
3.2 Validation
3.3 Primary Interviews
3.4 List of Data Sources
4 GLOBAL EUBIOTICS MARKET OUTLOOK
4.1 Overview
4.2 Market Dynamics
4.2.1 Drivers
4.2.2 Restraints
4.2.3 Opportunities
4.3 Porters Five Force Model
4.4 Value Chain Analysis
4.5 Regulatory Framework
5 GLOBAL EUBIOTICS MARKET BY TYPE
5.1 Overview
5.2 Prebiotics
5.3 Probiotics
5.4 Organic Acids
5.5 Essential oils
6 GLOBAL EUBIOTICS MARKET BY FORM
6.1 Overview
6.2 Liquid form
6.3 Dry form
7 GLOBAL EUBIOTICS MARKET BY FUNCTION
7.1 Overview
7.2 Yield
7.3 Nutrition & Gut Health
7.4 Immunity
7.5 Productivity
8 GLOBAL EUBIOTICS MARKET BY LIVESTOCK
8.1 Poultry
8.2 Ruminants
8.3 Aquatic Animals
8.4 Swine
8.5 Others
9 GLOBAL EUBIOTICS MARKET BY GEOGRAPHY
9.1 Overview
9.2 North America Regional Market Estimates and Forecasts, 2012 - 2025
9.2.1 U.S.
9.2.2 Canada
9.2.3 Mexico
9.3 Europe Regional Market Estimates and Forecasts, 2012 - 2025
9.3.1 Germany
9.3.2 U.K.
9.3.3 France
9.3.4 Rest of Europe
9.4 Asia Pacific Regional Market Estimates and Forecasts, 2012 - 2025
9.4.1 China
9.4.2 Japan
9.4.3 India
9.4.4 Rest of Asia Pacific
9.5 Latin America Regional Market Estimates and Forecasts, 2012 - 2025
9.5.1 Brazil
9.5.2 Argentina
9.6 Rest of the World Regional Market Estimates and Forecasts, 2012 - 2025
10 GLOBAL EUBIOTICS MARKET COMPETITIVE LANDSCAPE
10.1 Overview
10.2 Company Market Share
10.3 Vendor Landscape
10.4 Key Development Strategies
11 COMPANY PROFILES
11.1 BASF SE
11.1.1 Overview
11.1.2 Financial Performance
11.1.3 Product Outlook
11.1.4 Key Developments
11.2 Koninklijke DSM N.V.
11.2.1 Overview
11.2.2 Financial Performance
11.2.3 Product Outlook
11.2.4 Key Developments
11.3 Novozymes
11.3.1 Overview
11.3.2 Financial Performance
11.3.3 Product Outlook
11.3.4 Key Developments
11.4 Lesaffre Group
11.4.1 Overview
11.4.2 Financial Performance
11.4.3 Product Outlook
11.4.4 Key Developments
11.5 Lallemand, Inc.
11.5.1 Overview
11.5.2 Financial Performance
11.5.3 Product Outlook
11.5.4 Key Developments
11.6 Behn Meyer Group
11.6.1 Overview
11.6.2 Financial Performance
11.6.3 Product Outlook
11.6.4 Key Developments
11.7 Advanced Bio Nutrition Corp
11.7.1 Overview
11.7.2 Financial Performance
11.7.3 Product Outlook
11.7.4 Key Developments
11.8 Cargill
11.8.1 Overview
11.8.2 Financial Performance
11.8.3 Product Outlook
11.8.4 Key Developments
11.9 E.I. Dupont De Nemours and Company
11.9.1 Overview
11.9.2 Financial Performance
11.9.3 Product Outlook
11.9.4 Key Developments
11.10 Chr. Hansen Holding A/S
11.10.1 Overview
11.10.2 Financial Performance
11.10.3 Product Outlook
11.10.4 Key Developments
12 Appendix
12.1 Related Reports